Story thread · 6 reports / 5 sources
Takeda, Regeneron, Sanofi and Bristol Myers trim pipelines
endpts.com · 12d
How the coverage leans
Across 5 sources · syndicated copies counted once
Biopharma earnings season is also pipeline update season. On Wednesday, Takeda, Regeneron, Sanofi and Bristol Myers Squibb all announced program cuts as part of their quarterly updates. Some of the terminations were for early-stage programs: ...
First report: Bristol-Myers Squibb stock rating held at Market Perform by Raymond James — investing.com, 15d
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.